Literature DB >> 20887948

Benefits of utilizing gene-modified iPSCs for clinical applications.

James Ellis, Christopher Baum, Nissim Benvenisty, Gustavo Mostoslavsky, Hideyuki Okano, William L Stanford, Matthew Porteus, Michel Sadelain.   

Abstract

Mesh：

Year:  2010        PMID： 20887948     DOI： 10.1016/j.stem.2010.09.010

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


× No keyword cloud information.
  9 in total

1.  The stem cell "tunnel" effect.

Authors:  Thomas P Zwaka
Journal:  Mol Ther       Date:  2010-12       Impact factor: 11.454

Review 2.  Gene Insertion Into Genomic Safe Harbors for Human Gene Therapy.

Authors:  Eirini P Papapetrou; Axel Schambach
Journal:  Mol Ther       Date:  2016-02-12       Impact factor: 11.454

3.  Site-specific recombinase strategy to create induced pluripotent stem cells efficiently with plasmid DNA.

Authors:  Marisa Karow; Christopher L Chavez; Alfonso P Farruggio; Jonathan M Geisinger; Annahita Keravala; W Edward Jung; Feng Lan; Joseph C Wu; Yanru Chen-Tsai; Michele P Calos
Journal:  Stem Cells       Date:  2011-11       Impact factor: 6.277

Review 4.  State-of-the-art human gene therapy: part I. Gene delivery technologies.

Authors:  Dan Wang; Guangping Gao
Journal:  Discov Med       Date:  2014 Jul-Aug       Impact factor: 2.970

5.  Modified lentiviral LTRs allow Flp recombinase-mediated cassette exchange and in vivo tracing of "factor-free" induced pluripotent stem cells.

Authors:  Johannes Kuehle; Soeren Turan; Tobias Cantz; Dirk Hoffmann; Julia D Suerth; Tobias Maetzig; Daniela Zychlinski; Christoph Klein; Doris Steinemann; Christopher Baum; Juergen Bode; Axel Schambach
Journal:  Mol Ther       Date:  2014-01-17       Impact factor: 11.454

6.  Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy.

Authors:  Maria Themeli; Christopher C Kloss; Giovanni Ciriello; Victor D Fedorov; Fabiana Perna; Mithat Gonen; Michel Sadelain
Journal:  Nat Biotechnol       Date:  2013-08-11       Impact factor: 54.908

Review 7.  Retroviral vectors: post entry events and genomic alterations.

Authors:  Ali Nowrouzi; Hanno Glimm; Christof von Kalle; Manfred Schmidt
Journal:  Viruses       Date:  2011-04-29       Impact factor: 5.048

Review 8.  Regulatory and Scientific Advancements in Gene Therapy: State-of-the-Art of Clinical Applications and of the Supporting European Regulatory Framework.

Authors:  Marta Carvalho; Bruno Sepodes; Ana Paula Martins
Journal:  Front Med (Lausanne)       Date:  2017-10-26

9.  iPS cells generation: an overview of techniques and methods.

Authors:  Sa Telpalo-Carpio; Jm Aguilar-Yañez; Mt Gonzalez-Garza; DE Cruz-Vega; Je Moreno-Cuevas
Journal:  J Stem Cells Regen Med       Date:  2013-04-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.